BRCA1 and breast carcinoma: Smad3 interacts with BRCA1 in response to TGF-β stimulation and inhibits BRCA1-dependent DNA repair in MCF7 breast cancer cells (luminal type) by disrupting BRCA1 nuclear complexes (192).